SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-17-002300
Filing Date
2017-09-13
Accepted
2017-09-13 14:57:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d11247kam_09132017.htm SC 13D 244470
2 JOINT FILING AGREEMENT ex991to13d11247kam_09132017.htm EX-99.1 6230
  Complete submission text file 0000921895-17-002300.txt   252239
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Subject) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87516 | Film No.: 171083021
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11 MENACHEM BEGIN RD. RAMAT-GAN L3 5268104
Business Address 11 MENACHEM BEGIN RD. RAMAT-GAN L3 5268104 972-77-3206050
Brosh Capital Partners L.P. (Filed by) CIK: 0001703304 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D